Therapy in Biological Technology

United States FDA Clears the REGEN Trial to Test Bioheart's Combination Gene and Stem Cell Therapy in Heart Failure Patients

SUNRISE, Fla., July 28 /PRNewswire-FirstCall/ -- Bioheart, Inc., (OTC Bulletin Board: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases announced today that the US FDA cleared a p...

Progenitor Cell Therapy Appoints VP of Manufacturing Operations

PCT Recruits Experienced Pharmaceutical Production Executive to Head its Two U.S. Contract Manufacturing Facilities Hackensack, NJ (Vocus) July 13, 2009 -- Progenitor Cell Therapy, LLC (PCT) today announced the recent appointment of Daryl LeSueur as Vice President of ...

Hill-Rom Announces Sale of Negative Pressure Wound Therapy Intellectual Property

BATESVILLE, Ind., June 29 /PRNewswire-FirstCall/ -- Hill-Rom (NYSE: HRC ) today announced the sale of Hill-Rom's patents and intellectual property relating to Negative Pressure Wound Therapy (NPWT) to Kinetic Concepts, Inc. (NYSE: KCI ). Hill-Rom's NPWT portfolio included U.S. and f...

New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance

Faster reporting aids physicians in identifying HIV mutations that can inhibit effectiveness of newest class of antiretroviral therapy MADISON, N.J., June 12 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX ), the world's leading provider of diagnostic testing, informatio...

The World's Smallest Hero! Rexin-G, Targeted Therapy for Metastatic Cancers

SAN MARINO, Calif., June 9 /PRNewswire/ -- Epeius Biotechnologies' Rexin-G is the world's smallest hero ( www.epeiusbiotech.com ). Imagine if you will, a tiny particle that can travel freely within the human body seeking out cancerous tissues and metastatic tumors that have spread far and wide. ...

Dutch Medical Equipment Producer Nucletron Strengthens Leading Position in Cancer Radiation Therapy Market

VEENENDAAL, The Netherlands, June 2 /PRNewswire/ -- Nucletron BV, the innovative cancer radiation solutions company, today announced the creation of an exclusive partnership and plan to merge with sector peer Isodose Control BV for an undisclosed sum. The two companies, headquartered in Veenen...

ALS Therapy Development Institute, the World's Largest Non-Profit Biotech, Appoints Steve Perrin, Ph.D., as Chief Executive Officer

Board of Directors Also Appoints a New President and Adds A New Member CAMBRIDGE, Mass., May 1 /PRNewswire-USNewswire/ -- Steve Perrin, Ph.D., was appointed chief executive officer and Maureen Lister was appointed president of the ALS Therapy Development Institute (ALS TDI) during the annual ...

SeqWright Expands into the Genetically-Targeted Therapy Field by Partnering with PharmaGenoma to Provide Next-Generation Hair Loss Treatment Genetic Testing

HOUSTON, April 28 /PRNewswire/ -- SeqWright Inc., a CLIA certified and GLP compliant provider of custom genomic and molecular biology services, announced today its entry into the genetically-targeted therapy field through its partnership with PharmaGenoma. SeqWright will be the exclusive genetic ...

Z Therapy Is The First In North Texas To Offer Revolutionary Treatment Option For Neck Pain Sufferers

Z Therapy Whiplash Treatment Center now offers a ground-breaking treatment option for victims of whiplash associated disorders (WAD). With the introduction of a multi-cervical unit (MCU) by BTE Technologies, Z Therapy is the first and only rehabilitation specialist in North Texas to offer this t...

Thoratec Announces Filing of PMA Seeking Destination Therapy Approval for HeartMate II(R)

PLEASANTON, Calif., April 20 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR ), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that it has filed a PMA (Pre-Market Approval) supplement with the FDA seeki...

New 'near-field' radiation therapy promises relief for overheating laptops

Our modern age has become accustomed to regular improvements in information technology, says Slava Rotkin, but these advances do not come without a cost. Take the laptop, for example. Its components, especially its billions of semiconductor electronic circuits, are growing ever tinier while the...

ThermoGenesis Announces Abstracts to Be Presented at Upcoming Stem Cell Therapy Conference

RANCHO CORDOVA, Calif., April 2 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL ), a leading supplier of innovative products and services that process and store adult stem cells, said today that its devices will be the subject of several scientific abstracts to be presented at the ...

Heart Hospital of Austin First Site in World to Test Efficacy of New Adult Stem Cell Therapy to Treat Damaged Heart Tissue in Phase II Trial

Central Texas man receives groundbreaking therapy days after heart attack AUSTIN, Texas, March 31 /PRNewswire/ -- On March 30, the Heart Hospital of Austin treated the first patient in the world enrolled in a groundbreaking Phase II study designed to test the effectiveness and safety of a...

Video: Accera Launches Axona(TM), First Medical Food Therapy to Help Manage Mild-to-Moderate Alzheimer's Disease

BROOMFIELD, Colo., March 2 /PRNewswire/ -- Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system (CNS) diseases, today launched Axona(TM) in the United States for Alzheimer's disease (AD). Axona is a first-in-class medical food for the clinical dietary...

ProCure Signs Agreement with .decimal, Inc. to Purchase Patient-Specific Devices for Its Proton Therapy Center in Oklahoma City

SANFORD, Fla., Feb. 3 /PRNewswire/ -- .decimal, Inc. announced today that it has signed an agreement with ProCure Treatment Centers, Inc. to supply patient-specific devices for its proton therapy facility in Oklahoma City, Oklahoma. (Logo: http://www.newscom.com/cgi-bin/prnh/20090203/...

Victhom Human Bionics Receives CE Mark for the Neurostep(TM) System, the World's First Fully Implantable Closed-Loop Neuromodulation Therapy for Treatment of Foot Drop

QUEBEC CITY, Feb. 3 /PRNewswire-FirstCall/ - Victhom Human Bionics Inc., "Victhom" (TSX:VHB), announced today that its Neurobionix division has obtained CE Mark approval for its Neurostep(TM) System, the first ever approval for a closed-loop system (CLS) used on peripheral nerves. CE Mark represen...

Gene Therapy Field Advances With Important Clinical Findings Reported in the New England Journal of Medicine

SAN DIEGO, Calif., Feb. 3 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE: CXM ) today reported on recent clinical findings published in The New England Journal of Medicine showing the long-term outcome of a method of gene therapy to treat infant children with a fatal disorder of the im...

Inverseon's Asthma Therapy Receives Notice of Allowance; Clinical Trial Highlighted in Lancet

SAN FRANCISCO, Jan. 14 /PRNewswire/ -- Inverseon, Inc. ( http://www.inverseon.com ) announces the receipt of a notice of allowance from the United States Patent Office covering its oral product INV102 for asthma. Additionally, a comment highlighting Inverseon's clinical asthma study was published ...

Victhom announces the completion of the second phase of the apnea therapy development

QUEBEC, Jan. 12 /PRNewswire-FirstCall/ - Victhom Human Bionics Inc., "Victhom" (TSX: VHB), announced today the filing of an additional patent for the detection and treatment of sleep apnea and has also disclosed the preliminary results from its preclinical studies. The Company has recently filed...

Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia

Results of Two Trials Identify Potential Initiation Dosing Regimen TITUSVILLE, N.J., Dec. 10 /PRNewswire/ -- Paliperidone palmitate, an investigational long-acting therapy (LAT) demonstrated statistically significant symptom control compared with placebo according to the results of a 13-w...

OGX-011 Shows Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study

First-line trial currently shows median overall survival of 27.5 months for OGX-011 in combination with docetaxel and prednisone and a 16.9 months overall survival for docetaxel and prednisone alone. Achievement of survival benefit milestone results in release of ...

Pilot Study Finds Adding Topical Imiquimod To Laser Therapy Improves The Response Of Port Wine Stain Birthmarks

Two-thirds of all port wine stain birthmarks occur on the face. As such, there is a strong need for an effective, long-lasting treatment that safely fades these reddish-purple skin lesions that can have a huge impact on a patient's physical and emotional well-being. Now, a new study evaluating ...

World Gene Therapy Market to Reach $484 Million by 2015, According to New Report by Global Industry Analysts, Inc.

Gene therapy promises to be one of the most important frontiers in medicine. Although no significant achievements for curing disease have been achieved, the future seems to hold significant potential in terms of developing such approaches. By the year 2015, global market for gene therapy is proje...

Singapore Medicine - Breakthrough Development of Cell Therapy Treatment for Cancer

Singapore has embarked on a cell-based clinical trial that may have far-reaching implications for future cancer research and treatments. Singapore (PRWEB) October 29, 2008 -- Singapore has embarked on a cell-based clinical trial that may have far-reaching implications f...

Exiqon Announces Positive Clinical Data From EORTC Clinical Trial Showing Oncotech EDR Assay Predicts Resistance to Platinum-Based Therapy in Ovarian Cancer

VEDBAEK, Denmark, October 27 /PRNewswire-FirstCall/ -- The European Organization for Research and Treatment of Cancer (EORTC) has undertaken a multi-institutional prospective randomized clinical trial on 719 late stage epithelial ovarian cancer patients (named 55971). Results were announced to...

Radiation Therapy Oncology Group and US Oncology Enter Collaboration to Increase Patient Access to National Clinical Trials

Collaboration Brings Cooperative Group Level Radiation Therapy Trials to US Oncology Affiliates' Patients for First Time HOUSTON, Oct. 16 /PRNewswire/ -- The Radiation Therapy Oncology Group (RTOG) and US Oncology, Inc. today announced they have entered into a collaboration to incre...

Positive Preclinical Data on Cell Therapy for Spinal Disc Repair Presented at 23rd Annual Meeting of the North American Spine Society

ST. LOUIS, Oct. 16 /PRNewswire/ -- ISTO Technologies, Inc., a privately held orthobiologics company, today announced positive preclinical data related to its NuQu(TM) injectable cell-based therapy for spinal disc repair. The data was presented in Toronto, Canada at the 23rd Annual Meeting of t...

Arobella Medical CEO is Issued U.S. Patent for Ultrasound Wound Therapy Technology

Patent will protect next generation of Qoustic Wound Therapy System(R) MINNEAPOLIS, Oct. 9 /PRNewswire/ -- Arobella Medical, LLC, a leader in advanced ultrasonic wound care devices, today announced that its Co-founder, President and CEO Eliaz Babaev, Ph.D., has been issued a U.S. patent that ...

New Partnership Integrates Vibration Therapy Into Stem Cell Procedures

AUSTIN, Texas and TORONTO, Oct. 3 /PRNewswire/ -- Two leading companies in their respective industries are joining forces to integrate vibration therapy into the stem cell harvesting process. SpineSmith Partners LP, an orthopedic biotech company based in Austin, Texas, has signed an exclusiv...

Spectral to bring anti-sepsis therapy to the U.S. market

TORONTO, Sept. 23 /PRNewswire-FirstCall/ - Spectral Diagnostics Inc. (TSX: SDI) today announced that it has agreed to key terms with Toray Industries Inc. of Japan to obtain the exclusive development and commercial rights in the U.S. for Toraymyxin(TM), a therapeutic for the treatment of sepsi...

Progenitor Cell Therapy Secures Industry Accreditation

AABB accreditation bolsters PCT's commitment to quality cord blood stem cell processing, storage, and distribution. Hackensack, NJ (PRWEB) October 10, 2008 -- Progenitor Cell Therapy, LLC (PCT) announced today that it has obtained AABB accreditation in the category of '...

Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery

- Clinical data showing unprecedented 89% reduction in risk of GIST relapse with use of Gleevec after surgery are basis for FDA, EMEA, Swissmedic filings - Historically, one in two patients experienced recurrence of GIST after surg...

Regenerative Medicine Appoints Cell Therapy Group Consultant to Editorial Board

Cell therapy industry consultant Lee Buckler appointed to Regenerative Medicine editorial board. Vancouver, BC (PRWEB) August 27, 2008 -- The Cell Therapy Group ( www.celltherapygroup.com ) announced today the appointment of its principle consultant, R. Lee Buckler, to ...

Reliant Technologies Announces Canadian Launch of Fraxel re:pair(R) Laser: A New Class of Treatment Therapy for CO2 Laser Skin Resurfacing

Fraxel re:pair(R) system receives Health Canada clearance to treat severe sun damage, sagging skin, vascular dyschromia and wrinkles MOUNTAIN VIEW, Calif., Aug. 19 /PRNewswire/ -- Reliant Technologies, Inc., the pioneer of fractional resurfacing and market leader of aesthetic laser skin t...

Lixte Biotechnology Holdings Announces Filing of a New Patent Application for Cancer Therapy Based on Targeting a Biomarker by Novel Investigational Agents

EAST SETAUKET, N.Y., Aug. 19 /PRNewswire-FirstCall/ -- Lixte Biotechnology Holdings, Inc. (OTC Bulletin Board: LIXT) announced today that the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH) and Lixte filed a joint patent application identify...

ALS Therapy Development Institute and California Stem Cell, Inc. Announce Long-Term Scientific Collaboration

Bi-coastal collaboration aimed at applying stem cell technology to an 'orphan disease' in a unique translational research setting CAMBRIDGE, Mass. and IRVINE, Calif., July 29 /PRNewswire-USNewswire/ -- ALS Therapy Development Institute (ALS TDI) and California Stem Cell, Inc. (CSC) announced ...

Video: New, Advanced Therapy Program Helps People Who Stutter Acquire Fluent Speech

Hollins Communications Research Institute Forges New Ground in the Treatment of Stuttering ROANOKE, Va., July 15 /PRNewswire/ -- Scientists at Hollins Communications Research Institute (HCRI), a non-profit research and clinical center ( http://www.stuttering.org ) s...

AMT Starts Collaboration With St. Jude Children's Research Hospital on Gene Therapy for Hemophilia B. Company Accesses Exclusive Commercial Rights to Final Therapy

AMSTERDAM, The Netherlands, July 15 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced the start of a collaboration with St. Jude Children's Research Hospital in Memphis, Tennessee, USA, on the development of...

Two New Jersey Hormone Therapy Lawsuits Dismissed

MADISON, N.J., July 14 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE ) announced today that Judge Jamie D. Happas of the New Jersey Superior Court in New Brunswick has granted Wyeth's motion for summary judgment in two hormone therapy cases that were scheduled for trial later this year. The cour...

AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury

Biotech innovator develops new therapies based on cells manufactured from bone marrow; SV Life Sciences and Novo A/S provide funding round SALT LAKE CITY and HAMBURG, Germany, July 2 /PRNewswire/ -- AlloCure Inc., a biotechnology company at the forefront of innovative cell therapies for the ...